Sanders Morris Harris’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-56
| Closed | -$14.7K | – | 257 |
|
|
2022
Q4 | $14.7K | Sell |
56
-1,405
| -96% | -$370K | 0.01% | 207 |
|
|
2022
Q3 | $395K | Sell |
1,461
-815
| -36% | -$220K | 0.1% | 164 |
|
|
2022
Q2 | $812K | Sell |
2,276
-2,930
| -56% | -$1.05M | 0.18% | 88 |
|
|
2022
Q1 | $3.19M | Buy |
5,206
+847
| +19% | +$518K | 0.62% | 27 |
|
|
2021
Q4 | $2.92M | Buy |
4,359
+1,306
| +43% | +$875K | 0.51% | 36 |
|
|
2021
Q3 | $3.08M | Buy |
3,053
+953
| +45% | +$963K | 0.56% | 34 |
|
|
2021
Q2 | $3.08M | Buy |
2,100
+2,044
| +3,650% | +$3M | 0.6% | 29 |
|
|
2021
Q1 | $144K | Sell |
56
-2,000
| -97% | -$5.14M | 0.03% | 281 |
|
|
2020
Q4 | $4.23M | Buy |
2,056
+574
| +39% | +$1.18M | 0.96% | 23 |
|
|
2020
Q3 | $4.06M | Buy |
+1,482
| New | +$4.06M | 1.1% | 16 |
|
|
2020
Q2 | – | Sell |
-25
| Closed | -$42K | – | 232 |
|
|
2020
Q1 | $42K | Sell |
25
-487
| -95% | -$818K | 0.04% | 116 |
|
|
2019
Q4 | $1.27M | Sell |
512
-104
| -17% | -$259K | 0.29% | 93 |
|
|
2019
Q3 | $539K | Buy |
616
+136
| +28% | +$119K | 0.13% | 137 |
|
|
2019
Q2 | $572K | Buy |
+480
| New | +$572K | 0.15% | 131 |
|